News and Opinions
Diabetes took over her life, until a stem cell therapy freed her
By Carolyn Y. Johnson - The Washington Post - For years, Amanda Smith and her husband were jolted awake at night by a buzz-buzz-beep — an alarm warning that her blood sugar was too high or too low. She would reach for juice boxes stored in her nightstand or fiddle...
Brand New Publication: Nucleic Acid Therapeutics
By Mary Ann Liebert, Inc Publishers - This cover illustrates the original research report submitted by Anastasia Khvorova of the RNA Therapeutics Institute, University of Massachusetts Chan Medical School. This gorgeous image depicts the observation that nuclear...
Understanding CAR-T cell therapy for cancer: A promising, less arduous cancer treatment
By Sara Youngblood Gregory - Mayo Clinic - For many scientists and doctors, immunotherapy that uses someone’s own immune system to target and attack cancer cells is the next and best frontier of cancer treatment. Over the last decade, immunotherapy-focused research...
Discoveries from human stem cell research in space that are relevant to advancing cellular therapies on Earth
By Fay Ghani, Abba C. Zubair - Nature - Stem cell research performed in space has provided fundamental insights into stem cell properties and behavior in microgravity including cell proliferation, differentiation, and regeneration capabilities. However, there is...
Zebrafish use surprising strategy to regrow spinal cord
by Julia Evangelou Strait - Washington University College of Medicine - Detailed blueprint of nerve cells’ dramatic changes could help identify ways to heal spinal cord damage. Zebrafish are members of a rarefied group of vertebrates capable of fully healing a severed...
New way to extend ‘shelf life’ of blood stem cells will improve gene therapy
By University of Cambridge - Researchers have discovered a way to extend the shelf life of blood stem cells outside the body for use in gene therapy, providing patients with better options and improving their outcomes. We were able to identify a key molecular...
Understanding the Risk of Second Cancers After CAR T-Cell Therapy
By The National Cancer Institute - In November 2023, the Food and Drug Administration announced that it was investigating more than 20 instances of second cancers—specifically, T-cell lymphomas—in people who had been treated with CAR T-cell therapies. In several...
Astrocytes Are a Key Player in the Awakeneing of Dormant Neural Stem Cells
By Technology Networks - Research offers new hope for treating neurodevelopmental disorders by activating dormant neural stem cells. Scientists from Duke-NUS Medical School and the Mechanobiology Institute (MBI) at the National University of Singapore (NUS) have...
UofL cardiologist leading clinical trial for high potential new therapy for heart failure
By University of Louisville School of Medicine - A new stem cell therapy for heart failure is being tested in patients at the University of Louisville and UofL Health. The trial is the first in the U.S. to test umbilical cord-derived stem cells in patients for heart...
UofL cardiologist leading clinical trial for high potential new therapy for heart failure
By University of Louisville School of Medicine - A new stem cell therapy for heart failure is being tested in patients at the University of Louisville and UofL Health. The trial is the first in the U.S. to test umbilical cord-derived stem cells in patients for heart...
Next-generation CRISPR-based gene-editing therapies tested in clinical trials
By Natalie Healey - Nature Medicine Going from the laboratory to an approved therapy in 11 years is no mean feat. That is the story of the world’s first approved CRISPR–Cas9 therapy, greenlit by the US Food and Drug Administration in December 2023....
First Engineered T Cell Therapy for Solid Tumors Approved by the FDA
By Inside Precision Medicine - The immunotherapy afamitresgene autoleucel (afami-cel) for the treatment of adults with the rare soft tissue cancer called synovial sarcoma was granted accelerated approval late last week by the U.S. Food and Drug Administration (FDA)....
Researchers decipher new molecular mechanisms related to biological tissue regeneration
By University of Barcelona - A study published in The EMBO Journal opens new perspectives to better understand how the molecular mechanisms involved in regenerative medicine work. The study focuses on tumour necrosis factor-α (TNF-α) and its receptors TNFR, molecules...
Breaking the Chains: How CRISPR Gene Therapy Gave Victoria Gray a New Life
by Molly Coddington - Technology Networks - Like many young girls in elementary school, Victoria Gray wanted to be a cheerleader, until she was told by her doctor that this simply wouldn’t be possible; the exertion placed on her body by the training regimen could have...
Detecting pancreatic cancer through changes in body composition and metabolism
by Marla Broadfoot, Ph.D. - Mayo Clinic - Pancreatic cancer is a formidable disease, often diagnosed too late for effective treatment. However, new research from Mayo Clinic represents a promising step toward identifying biological signals or biomarkers that may aid...
Cell donors are essential for new therapies. They need to be taken care of
By Priya Baraniak - STAT News - Cutting-edge FDA-approved therapies made from human cells are now being used to treat cancer, diabetes, and other diseases. Currently, most approved cell-based therapies use an individual’s own cells, but the next generation of these...
New study shows ‘dancing molecules’ can regenerate cartilage in 3 days
By Medical Xpress News - In November 2021, Northwestern University researchers introduced an injectable new therapy, which harnessed fast-moving "dancing molecules," to repair tissues and reverse paralysis after severe spinal cord injuries. Now, the same research...
DA Grants Regenerative Medicine Advanced Therapy Designation for AIC100 to Treat Thyroid Cancer
By Kennedy Ferruggia - Pharmacy Times - The FDA has granted regenerative medicine advanced therapy (RMAT) designation for AIC100 (Affylmmune Therapeutics), an ICAM-1 targeting and affinity-tuned LFA-1 binder chimeric antigen receptor (CAR) T-cell therapy product...
Deciphering the journey from stem cells to neurons
By Riken Research News - RIKEN researchers have uncovered how gradual changes in gene-expression patterns drive a cell-fate switch in neural stem cells (NSCs) in mice1. All the major neuronal types of cells in the central nervous system are created through the...
Fighting leukaemia by targeting its stem cells
By University of Geneva - Acute myeloid leukaemia is one of the deadliest cancers. Leukaemic stem cells responsible for the disease are highly resistant to treatment. A team from the University of Geneva (UNIGE), University Hospital of Geneva (HUG), and Inserm has...
Join Regenerative Medicine Foundation
Join today and get access to our newsletter and exclusive updates about events
and all things happening with regenerative medicine.
Join Our Mailing List
The Regenerative Medicine Foundation is a non-profit organization, granted tax-exempt status under Section 501(c)(3) of the United States Internal Revenue Code. Contributions are tax-deductible to the extent allowable by law.
Copyright © 2025 Regenerative Medicine Foundation, All rights reserved.

















